jofinЖурнал инфектологииJournal Infectology2072-6732IPO “АIDSSPbR"10.22625/2072-6732-2011-3-3-114-119jofin-53Research ArticleКлинический случайClinical CaseВАСКУЛИТ КОЖИ У ПАЦИЕНТКИ С ХРОНИЧЕСКИМ ГЕПАТИТОМ С, СМЕШАННОЙ КРИОГЛОБУЛИНЕМИЕЙ И АКТИВНО ТЕКУЩЕЙ ХРОНИЧЕСКОЙ ЦИТОМЕГАЛОВИРУСНОЙ ИНФЕКЦИЕЙ (описание клинического случая)Vasсulitis of skin at the patient with a chronic hepatitis C, the admixed сryoglobulinemia and activity current chronic CMV infection (the description of a clinical case)СулимаД. Л.SulimaD. L.

профессор кафедры инфекционных болезней и эпидемиологии с курсом ВИЧ-медицины СПбГМУ им. акад. И.П. Павлова, д.м.н.; тел: 8(905)252-55-77

uncledimamed@mail.ruГорчаковаО. В.GorchakovaO. V.

научный сотрудник лаборатории хронических вирусных инфекций НИЦ при кафедре инфекционных болезней и эпидемиологии с курсом ВИЧ-медицины СПбГМУ им. акад. И.П. Павлова, к.м.н.; тел: 8(812)499-70-58

infection@spmu.rssi.ruСабадашН. В.SabadashN. V.

доцент кафедры инфекционных болезней и эпидемиологии с курсом ВИЧ-медицины СПбГМУ им. акад. И.П. Павлова, к.м.н.; тел: 8(812)499-70-58

КаревВ. Е.KarevV. E.

заведующий лабораторией патоморфологии ФГУ «НИИ детских инфекций ФМБА России»; к.м.н.; тел.: 8(812)234-96-23

karev@fromru.comЛабазановВ. М.LabazanovV. M.

врач-хирург, ординатор 19 ХО СПб ГУЗ «Клиническая инфекционная больница им. С.П. Боткина»; тел: 8(812)717-44-40

v.labazanov@mail.ruСанкт-Петербургский государственный медицинский университет им. академика И.П. Павлова, Санкт-ПетербургРоссияSaint-Petersburg State Medical University by I.P. Pavlov, Saint-PetersburgRussian FederationНаучно-исследовательский институт детских инфекций ФМБА России, Санкт-ПетербургРоссияResearch Institute of Children Infection Diseases FMBA of Russia, Saint-PetersburgRussian FederationКлиническая инфекционная больница им. С.П. Боткина, Санкт-ПетербургРоссияClinical Infection Diseases Hospital named by S.P. Botkin, Saint-PetersburgRussian Federation20110609201433114119Copyright © Сулима Д.Л., Горчакова О.В., Сабадаш Н.В., Карев В.Е., Лабазанов В.М., 20142014Сулима Д.Л., Горчакова О.В., Сабадаш Н.В., Карев В.Е., Лабазанов В.М.Sulima D.L., Gorchakova O.V., Sabadash N.V., Karev V.E., Labazanov V.M.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.niidi.ru/jofin/article/view/53

.

.

ReferencesЯкобсон, И.М. Внепеченочные проявления хронического гепатита С / И.М. Якобсон [и др.] // Клин. гастроэнтерол. и гепатол. – 2011. – Т. 4, № 1. – С. 55–68.Якобсон, И.М. Внепеченочные проявления хронического гепатита С / И.М. Якобсон [и др.] // Клин. гастроэнтерол. и гепатол. – 2011. – Т. 4, № 1. – С. 55–68.Zignego, A.L. Extrahepatic manifestations of hepatitis C virus infection: A general overview and guidelines for a clinical approach / A.L. Zignego [et al.] // Dig. Liver Dis. – 2007. – V. 39. – P. 2–17.Zignego, A.L. Extrahepatic manifestations of hepatitis C virus infection: A general overview and guidelines for a clinical approach / A.L. Zignego [et al.] // Dig. Liver Dis. – 2007. – V. 39. – P. 2–17.Monti, G. Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias / G. Monti [et al.] // Arch. Intern. Med. – 2005. – V. 165. – P. 101–105.Monti, G. Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias / G. Monti [et al.] // Arch. Intern. Med. – 2005. – V. 165. – P. 101–105.Fabrizi, F. Therapy of hepatitis C virus-associated glomerulonephritis: Current approaches / F. Fabrizi [et al.] // J. Nephrol. – 2008. – V. 21. – P. 813–825.Fabrizi, F. Therapy of hepatitis C virus-associated glomerulonephritis: Current approaches / F. Fabrizi [et al.] // J. Nephrol. – 2008. – V. 21. – P. 813–825.Harrison, S.A. Insulin resistance among patients with chronic hepatitis C: Etiology and impact on treatment / S.A. Harrison // Clin. Gastroenterol. Hepatol. – 2008. – V. 6.– P. 864–876.Harrison, S.A. Insulin resistance among patients with chronic hepatitis C: Etiology and impact on treatment / S.A. Harrison // Clin. Gastroenterol. Hepatol. – 2008. – V. 6.– P. 864–876.Moucari, R. Insulin resistance in chronic hepatitis C: Association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis / R. Moucari [et al.] // Gastroenterol. – 2008. – V. 134. – P. 416–423.Moucari, R. Insulin resistance in chronic hepatitis C: Association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis / R. Moucari [et al.] // Gastroenterol. – 2008. – V. 134. – P. 416–423.Wang, C.S. Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study /C.S. Wang [et al.] // Am. J. Epidemiol. – 2007. – V. 166. – P. 196–203.Wang, C.S. Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study /C.S. Wang [et al.] // Am. J. Epidemiol. – 2007. – V. 166. – P. 196–203.Hsu, F.C. Prevalence of rheumatoid arthritis and hepatitis C in those age 60 and older in a US population based study / F.C. Hsu [et al.] // J. Rheumatol. – 2003. – V. 30. – P. 455–458.Hsu, F.C. Prevalence of rheumatoid arthritis and hepatitis C in those age 60 and older in a US population based study / F.C. Hsu [et al.] // J. Rheumatol. – 2003. – V. 30. – P. 455–458.Fox, R.I. Sjogren’s syndrome / R.I. Fox // Lancet. – 2005. – V. 366. – P. 321–331.Fox, R.I. Sjogren’s syndrome / R.I. Fox // Lancet. – 2005. – V. 366. – P. 321–331.Leigh, J.P. Costs of hepatitis C / J.P. Leigh [et al.] //Arch. Intern. Med. – 2001. – V. 161. – P. 2231–2237.Leigh, J.P. Costs of hepatitis C / J.P. Leigh [et al.] //Arch. Intern. Med. – 2001. – V. 161. – P. 2231–2237.Casato, M. Central nervous system involvement in hepatitis C virus cryoglobulinemia vasculitis: A multicenter case-control study using magnetic resonance imaging and neuropsychological tests / M. Casato [et al.] //J. Rheumatol. – 2005. – V. 32. – P. 484–488.Casato, M. Central nervous system involvement in hepatitis C virus cryoglobulinemia vasculitis: A multicenter case-control study using magnetic resonance imaging and neuropsychological tests / M. Casato [et al.] //J. Rheumatol. – 2005. – V. 32. – P. 484–488.Spiegel, B.M. Impact of hepatitis C on health related quality of life: A systematic review and quantitative assessment /B.M. Spiegel [et al.] // Hepatology. – 2005. – V. 41. – P. 790–800.Spiegel, B.M. Impact of hepatitis C on health related quality of life: A systematic review and quantitative assessment /B.M. Spiegel [et al.] // Hepatology. – 2005. – V. 41. – P. 790–800.Cacoub, P. Cryoglobulinemia vasculitis / P. Cacoub [et al.] // Curr. Opin. Rheumatol. – 2002. – V. 14, № 1. – P. 29–35.Cacoub, P. Cryoglobulinemia vasculitis / P. Cacoub [et al.] // Curr. Opin. Rheumatol. – 2002. – V. 14, № 1. – P. 29–35.Ferri, C. Cryoglobulins / C. Ferri, A.L. Zignego, S.A. Pileri // J. Clin. Pathol. – 2002. – V. 55, № 1. – P. 413.Ferri, C. Cryoglobulins / C. Ferri, A.L. Zignego, S.A. Pileri // J. Clin. Pathol. – 2002. – V. 55, № 1. – P. 413.Younossi, Z. The effects of HCV infection and management on health-related quality of life / Z. Younossi, J. Kallman // J. Hepatol. – 2007. – V. 45. – P. 806–816.Younossi, Z. The effects of HCV infection and management on health-related quality of life / Z. Younossi, J. Kallman // J. Hepatol. – 2007. – V. 45. – P. 806–816.Ferri, C. Cryoglobulinemic vasculitis / C. Ferri, M.T. Mascia // Curr. Opin. Rheumatol. – 2006. – V. 18. – P. 54–63.Ferri, C. Cryoglobulinemic vasculitis / C. Ferri, M.T. Mascia // Curr. Opin. Rheumatol. – 2006. – V. 18. – P. 54–63.Saadoun, D. Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis / D. Saadoun [et al.] // Curr. Opin. Rheumatol. – 2008. – V. 20. – P. 23–28.Saadoun, D. Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis / D. Saadoun [et al.] // Curr. Opin. Rheumatol. – 2008. – V. 20. – P. 23–28.Saadoun, D. Involvement of chemokines and type 1 cytokines in the pathogenesis of hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy / D. Saadoun [et al.] // Rheumatol. – 2005. – V. 46. – P. 2917–2925.Saadoun, D. Involvement of chemokines and type 1 cytokines in the pathogenesis of hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy / D. Saadoun [et al.] // Rheumatol. – 2005. – V. 46. – P. 2917–2925.Saadoun, D. Hepatitis C-associated mixed cryoglobulinemia: A crossroad between autoimmunity and lymphoproliferation / D. Saadoun [et al.] // Rheumatol. – 2007. – V. 52. – P. 1234–1242.Saadoun, D. Hepatitis C-associated mixed cryoglobulinemia: A crossroad between autoimmunity and lymphoproliferation / D. Saadoun [et al.] // Rheumatol. – 2007. – V. 52. – P. 1234–1242.Cacoub, P. Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemia vasculitis: Where do we stand? / P. Cacoub [et al.] // Ann. Rheum. Dis. – 2008. – V. 67. – P. 283–287.Cacoub, P. Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemia vasculitis: Where do we stand? / P. Cacoub [et al.] // Ann. Rheum. Dis. – 2008. – V. 67. – P. 283–287.Cavallo, R. Rituximab in cryoglobulinemic peripheral neuropathy / R. Cavallo [et al.] // J. Neurol. – 2009. – V. 256. – P. 1076–1082.Cavallo, R. Rituximab in cryoglobulinemic peripheral neuropathy / R. Cavallo [et al.] // J. Neurol. – 2009. – V. 256. – P. 1076–1082.Saadoun, D. Rituximab plus peg-interferon/ribavirin compared to αpeg-interferon/ribavirin in hepatitis C related mixedα cryoglobulinemia / D. Saadoun [et al.] // Blood. – 2010. – V. 116. – P. 326–334.Saadoun, D. Rituximab plus peg-interferon/ribavirin compared to αpeg-interferon/ribavirin in hepatitis C related mixedα cryoglobulinemia / D. Saadoun [et al.] // Blood. – 2010. – V. 116. – P. 326–334.Lamprecht, P. Cryoglobulinemic vasculitis /P. Lamprecht, A. Gause, W.L. Gross // Arthritis and rheumatism. – 1999. – V. 42, № 12. – P. 2507–2516.Lamprecht, P. Cryoglobulinemic vasculitis /P. Lamprecht, A. Gause, W.L. Gross // Arthritis and rheumatism. – 1999. – V. 42, № 12. – P. 2507–2516.Тишкевич, О.А. Системный цитомегаловирусный васкулит у ВИЧ-инфицированного больного / О.А. Тишкевич [и др.] // Эпидемиология и инфекционные болезни. – 2001. – № 1. – С. 31–36.Тишкевич, О.А. Системный цитомегаловирусный васкулит у ВИЧ-инфицированного больного / О.А. Тишкевич [и др.] // Эпидемиология и инфекционные болезни. – 2001. – № 1. – С. 31–36.

The authors declare that there are no conflicts of interest present.